John L. Lubniewski, Chief Business Officer at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), sold 4,067 shares at $2.69 ($11K) on 2016-03-09, disclosed to the SEC on 2016-03-09.
Scheduled sale ($11k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HTGM | BUY | 2015-08-12 | $38K | — | Filing → |